Pulse Biosciences, Inc.

This study tests a new device called the CellFX nsPFA catheter, which uses short electrical pulses instead of heat to treat paroxysmal atrial fibrillation (a type of irregular heartbeat). The goal is to see if it is safe and effective at restoring normal rhythm in 215 adults who …

This study tests a new device called the CellFX Nano-PFA 360 catheter, which uses very short electrical pulses to treat atrial fibrillation (an irregular heartbeat). About 60 adults aged 18 to 75 with paroxysmal atrial fibrillation will receive this procedure. The goal is to see …

This study tests a new device that uses electrical pulses to shrink benign (non-cancerous) thyroid nodules. About 100 adults with symptomatic nodules will receive the treatment and be followed to see if the nodule shrinks and symptoms improve. The goal is to offer a less invasive…

This study tests a new device that uses short electrical pulses to treat atrial fibrillation (an irregular heartbeat) during heart surgery. About 30 adults aged 18 to 85 who need heart surgery and have a history of atrial fibrillation will take part. The device aims to create sca…

This study tests a new device that uses electrical pulses to treat atrial fibrillation (an irregular heartbeat) while patients undergo other heart surgery. About 135 adults aged 18-85 with a history of AFib will participate. The goal is to see if the device safely restores normal…